PROCEPT BioRobotics Corporation (PRCT) has a consensus analyst rating of Buy, based on 15 analysts covering the stock. Of those, 11 recommend buying, 3 recommend holding, and 1 recommend selling.
The analyst consensus price target for PRCT is $47.00, representing a +91.1% upside from the current price of $24.59. Price targets range from a low of $30.00 to a high of $62.00.
